Computational simulations on the binding and reactivity of a nitrile inhibitor of the SARS-CoV-2 main protease
- 10 August 2021
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (72) , 9096-9099
Abstract
Computational simulations unveil the inhibition mechanism of the SARS-CoV-2 main protease by a novel oral nitrile-containing inhibitor, PF-07321332.Keywords
All Related Versions
Funding Information
- Generalitat Valenciana (GVCOV19/Decreto180/2020)
This publication has 17 references indexed in Scilit:
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replicationNature Communications, 2020
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main proteaseScience, 2020
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main proteaseCell Research, 2020
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitorsScience, 2020
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitorsNature, 2020
- Adaptive Finite Temperature String Method in Collective VariablesThe Journal of Physical Chemistry A, 2017
- An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule ChemotherapyJournal of Medicinal Chemistry, 2016
- From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug designThe FEBS Journal, 2014
- Interaction of Papain-like Cysteine Proteases with Dipeptide-Derived NitrilesJournal of Medicinal Chemistry, 2005
- The immune control and cell-to-cell spread of human T-lymphotropic virus type 1Journal of General Virology, 2003